Prevention of Procedural Hypertension in the Irreversible Electroporation Ablation of Liver and Pancreatic Tumors Based on Distance from the Adrenal Gland
Clicks: 372
ID: 79463
2020
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
30.0
/100
372 views
54 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #11 of 31 articles by views in Cancer management and research
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Gang Fang, Lizhi Niu, Jibing Chen Fuda Cancer Hospital of Jinan University, Guangzhou 510665, People’s Republic of ChinaCorrespondence: Jibing
ChenFuda Cancer Hospital of Jinan University, No. 2 Of Tangdexi Road, Tianhe District, Guangzhou 510665, People’s Republic of ChinaEmail
jibingchen398@163.comBackground and objective: When irreversible electroporation (IRE) ablation of abdominal tumors, procedural hypertension often
occurs, which often affects the progress of the ablation. Until now, there is no reasonable explanation for this phenomenon. The objective of this research was to explore the
cause and solution of procedural hypertension in percutaneous IRE.Methods: In this study, the treatment data of 4 consecutive groups of patients were used
to confirm the cause of intraoperative hypertension and then verify the solution. A total of 155 patients with procedural hypertension were screened based on their medical
records of pancreatic or hepatic IRE treatment. Procedural hypertension was monitored in 21 new patients, the correlation between serum catecholamines and hypertension was
recorded and evaluated using regression analysis. Forty new patients were divided into two groups (distance from needle tip to adrenal gland, < 2 cm vs ≥ 2 cm), and the
blood pressure was recorded and compared with two-way ANOVA. Eleven patients with ablative distance < 2 cm were treated in advance with
phentolamine to observe for the occurrence of procedural hypertension.Results: Of the 21 re-enrolled patients with ablation of the pancreas and liver tumors, 9 developed intraoperative hypertension with
significantly elevated serum catecholamines levels, epinephrine, norepinephrine and dopamine are all positively associated with hypertension, with P values were 0.0003, 0.0253,
and 0.0015, respectively. For the two groups with different needle-insertion distances, hypertension in the < 2 cm group was more significant than that in the other group
(for procedural hypertension, P< 0.01; for heart rate, P< 0.05), which was considered as a high-risk group. The occurrence of intraoperative hypertension could be
completely prevented by using phentolamine prior to treatment.Conclusion: Hypertension occurs frequently during hepatic and pancreatic IRE because of the
damage of adrenal gland. The safe distance of ablation probe for the adrenal gland was 2 cm. For high-risk patients, early drug prevention works well.
Keywords: irreversible electroporation, abdominal tumor, procedural hypertension, adrenal gland, catecholamine, risky distance
| Reference Key |
g2020preventioncancer
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | G, Fang;L, Niu;J, Chen; |
| Journal | Cancer management and research |
| Year | 2020 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.